This edition of Orrick’s life sciences publication series breaks down the key drivers of venture investment in the life sciences industry during Q1 2022, which saw some disruptions following a record year in 2021.
Key findings include:
• The industry raised $11.7 billion across 407 deals in Q1 2022. Deal count was the lowest since Q3 2019, but deal value was consistent with the elevated levels of the past two years.
Please see full publication below for more information.
